Trek Financial LLC grew its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 23.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 12,701 shares of the conglomerate’s stock after purchasing an additional 2,450 shares during the quarter. Trek Financial LLC’s holdings in Danaher were worth $2,814,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Prime Capital Investment Advisors LLC grew its stake in shares of Danaher by 0.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 9,203 shares of the conglomerate’s stock worth $2,039,000 after purchasing an additional 45 shares during the last quarter. Essential Investment Partners LLC lifted its stake in Danaher by 34.6% during the third quarter. Essential Investment Partners LLC now owns 175 shares of the conglomerate’s stock valued at $39,000 after purchasing an additional 45 shares during the last quarter. Veery Capital LLC boosted its holdings in Danaher by 3.1% during the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock worth $350,000 after buying an additional 48 shares in the last quarter. Studio Investment Management LLC boosted its holdings in Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares in the last quarter. Finally, Meridian Financial Partners LLC grew its position in Danaher by 1.2% in the third quarter. Meridian Financial Partners LLC now owns 4,636 shares of the conglomerate’s stock worth $1,073,000 after buying an additional 56 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several research firms have issued reports on DHR. Robert W. Baird upped their price target on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a report on Thursday, October 22nd. Guggenheim raised their price objective on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. TD Cowen lifted their target price on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Finally, DZ Bank downgraded Danaher from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $242.91.
Get Our Latest Stock Report on DHR
Insider Activity
In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares in the company, valued at $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.80% of the stock is owned by insiders.
Danaher Stock Down 1.8%
DHR stock opened at $228.04 on Tuesday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company’s 50 day simple moving average is $219.09 and its 200-day simple moving average is $201.73. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29. The firm has a market capitalization of $160.44 billion, a P/E ratio of 37.32, a P/E/G ratio of 2.94 and a beta of 0.76.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter in the prior year, the firm earned $1.89 EPS. The firm’s quarterly revenue was up 8.3% on a year-over-year basis. As a group, equities research analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s payout ratio is 26.19%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.
The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.
Featured Articles
- Five stocks we like better than Danaher
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
